Molecular subtypes of bladder cancer and first success in personalized treatment
https://doi.org/10.17650/1726-9776-2020-16-1-106-113
Abstract
In the literature review we described studies, the main purpose of which was to distribute bladder tumors by molecular subtypes. A similar classification has long been actively used in the treatment of breast cancer. The pioneering work in the molecular subtypes of bladder cancer includes the work by Lund group, the TCGA (The Cancer Genome Atlas) project, the MD Anderson study. We have also included data on attempts to apply molecular taxonomy of bladder cancer in treatment.
About the Authors
V. K. Osetnik
Saint Petersburg State University Hospital
Russian Federation
154, Fontanka River Embankment, Saint Petersburg 190103
Russian Federation
154, Fontanka River Embankment, Saint Petersburg 190103
E. M. Mamizhev
Saint Petersburg State University Hospital
Russian Federation
154, Fontanka River Embankment, Saint Petersburg 190103
Russian Federation
154, Fontanka River Embankment, Saint Petersburg 190103
I. B. Dzalilov
Saint Petersburg State University Hospital
Russian Federation
154, Fontanka River Embankment, Saint Petersburg 190103
Russian Federation
154, Fontanka River Embankment, Saint Petersburg 190103
A. S. Artemyeva
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
68 Leningradskaya St., Pesochniji, Saint Petersburg 197758
Competing Interests: 197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68
Russian Federation
68 Leningradskaya St., Pesochniji, Saint Petersburg 197758
Competing Interests: 197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68
V. A. Kushnarev
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
68 Leningradskaya St., Pesochniji, Saint Petersburg 197758
Competing Interests: 197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68
Russian Federation
68 Leningradskaya St., Pesochniji, Saint Petersburg 197758
Competing Interests: 197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68
References
1. Kirkali, Ziya, et al. "Bladder cancer: epidemiology, staging and grading, and diagnosis." Urology 66.6 (2005): 4-34.
2. Seigel, R., D. Naishadham, and A. Jemal. "Cancer statistics, 2014." Ca Cancer J Clin 64.1 (2014): 9-29.
3. Simonis, K., Shariat, S. F., & Rink, M. (2014). Smoking and smoking cessation effects on oncological outcomes in nonmuscle invasive bladder cancer. Current opinion in urology, 24(5), 492-499.
4. Botteman, Marc F., et al. "The health economics of bladder cancer." Pharmacoeconomics 21.18 (2003): 1315-1330.
5. Shah, Jay B., David J. McConkey, and Colin PN Dinney. "New strategies in muscle-invasive bladder cancer: on the road to personalized medicine." Clinical Cancer Research 17.9 (2011): 2608-2612.
6. Rouzier, Roman, et al. "Breast cancer molecular subtypes respond differently to preoperative chemotherapy." Clinical cancer research11.16 (2005): 5678-5685.
7. Lindgren, David, et al. "Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome." Cancer research 70.9 (2010): 3463-3472.
8. Sjödahl, Gottfrid, et al. "A molecular taxonomy for urothelial carcinoma." Clinical cancer research 18.12 (2012): 3377-3386.
9. Lindgren, David, et al. "Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma." PloS one 7.6 (2012): e38863.
10. Sjödahl, Gottfrid, et al. "Toward a molecular pathologic classification of urothelial carcinoma." The American journal of pathology 183.3 (2013): 681-691.
11. Patschan, Oliver, et al. "A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma." European urology 68.5 (2015): 824-832.
12. Cancer Genome Atlas Research Network. "Comprehensive molecular characterization of urothelial bladder carcinoma." Nature 507.7492 (2014): 315.
13. Volkmer, Jens-Peter, et al. "Three differentiation states risk-stratify bladder cancer into distinct subtypes." Proceedings of the National Academy of Sciences 109.6 (2012): 2078-2083.
14. Ho, Philip Levy, Antonina Kurtova, and Keith Syson Chan. "Normal and neoplastic urothelial stem cells: getting to the root of the problem." Nature reviews Urology 9.10 (2012): 583.
15. Hoadley, Katherine A., et al. "Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin." Cell 158.4 (2014): 929-944.
16. Perou, Charles M., et al. "Molecular portraits of human breast tumours." Nature 406.6797 (2000): 747.
17. Sørlie, Therese, et al. "Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications." Proceedings of the National Academy of Sciences 98.19 (2001): 10869-10874.
18. Choi, Woonyoung, et al. "Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy." Cancer cell 25.2 (2014): 152-165.
19. Choi, Woonyoung, et al. "Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer." Nature Reviews Urology 11.7 (2014): 400.
20. McConkey, David J., Woonyoung Choi, and Colin PN Dinney. "New insights into subtypes of invasive bladder cancer: considerations of the clinician." European urology 66.4 (2014): 609-610.
21. Damrauer, Jeffrey S., et al. "Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology." Proceedings of the National Academy of Sciences 111.8 (2014): 3110-3115.
22. Lauss, Martin, et al. "DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status." Epigenetics7.8 (2012): 858-867.
23. Aine, Mattias, et al. "Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma." Genome medicine 7.1 (2015): 23.
24. Lerner, Seth P., et al. "Bladder cancer molecular taxonomy: summary from a consensus meeting." Bladder Cancer 2.1 (2016): 37-47.
25. Seiler, Roland, et al. "Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy." European urology 72.4 (2017): 544-554.
26. Liu, David, et al. "Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer." Nature communications 8.1 (2017): 2193.
27. Robertson, A. Gordon, et al. "Comprehensive molecular characterization of muscle-invasive bladder cancer." Cell 171.3 (2017): 540-556.
Review
For citations:
Osetnik V.K., Mamizhev E.M., Dzalilov I.B., Artemyeva A.S., Kushnarev V.A. Molecular subtypes of bladder cancer and first success in personalized treatment. Cancer Urology. 2020;16(1):106-113. (In Russ.) https://doi.org/10.17650/1726-9776-2020-16-1-106-113
Views:
1039
Email this article 